Show simple item record

dc.contributor.authorFrendl, Daniel M.
dc.contributor.authorEpstein, Mara M
dc.contributor.authorFouayzi, Hassan
dc.contributor.authorKrajenta, Richard
dc.contributor.authorRybicki, Benjamin A.
dc.contributor.authorSokoloff, Mitchell H.
dc.date2022-08-11T08:11:02.000
dc.date.accessioned2022-08-23T17:29:48Z
dc.date.available2022-08-23T17:29:48Z
dc.date.issued2020-09-01
dc.date.submitted2020-10-21
dc.identifier.citation<p>Frendl DM, Epstein MM, Fouayzi H, Krajenta R, Rybicki BA, Sokoloff MH. Prostate-specific antigen testing after the US Preventive Services Task Force recommendation: a population-based analysis of electronic health data. Cancer Causes Control. 2020 Sep;31(9):861-867. doi: 10.1007/s10552-020-01324-x. Epub 2020 Jun 17. PMID: 32556947; PMCID: PMC7384921. <a href="https://doi.org/10.1007/s10552-020-01324-x">Link to article on publisher's site</a></p>
dc.identifier.issn0957-5243 (Linking)
dc.identifier.doi10.1007/s10552-020-01324-x
dc.identifier.pmid32556947
dc.identifier.urihttp://hdl.handle.net/20.500.14038/50403
dc.description.abstractPURPOSE: This study describes longitudinal trends in the use of prostate-specific antigen (PSA)-based testing in two geographically distinct healthcare systems following the 2011 US Preventive Services Task Force (USPSTF) recommendations against routine PSA screening. METHODS: We analyzed population-based health claims data from 253,139 men aged 40-80 who were enrolled at two US healthcare systems. We assessed trends in the percentage of eligible men receiving >/= 1 PSA test per year by time period (2000-2008, 2009-2011, 2012-2014), age (40-54, 55-69, 70-80), and race (white, black, other, unknown), and conducted a joinpoint regression analysis. RESULTS: Men aged 55-69 and 70-80 years of all races had similar use of PSA testing between 2000 and 2011, ranging between 47 and 56% of eligible men by year, while only 22-26% of men aged 40-54 had a PSA test per year during this period. Overall, the percentage of men receiving at least one PSA test per year decreased by 26% between 2009-2011 and 2012-2014, with similar trends across race and age groups. PSA testing declined significantly after 2011 (annual percent change = - 11.28). CONCLUSIONS: Following the 2011 USPSTF recommendations against routine PSA screening, declines in PSA testing were observed among men of all races and across all age groups in two large US healthcare systems.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=32556947&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.1007/s10552-020-01324-x
dc.subjectHealthcare claims
dc.subjectProstate cancer
dc.subjectProstate-specific antigen
dc.subjectScreening
dc.subjectUMCCTS funding
dc.subjectCommunity Health and Preventive Medicine
dc.subjectEpidemiology
dc.subjectHealth Information Technology
dc.subjectHealth Services Administration
dc.subjectHealth Services Research
dc.subjectPreventive Medicine
dc.subjectTranslational Medical Research
dc.subjectUrology
dc.titleProstate-specific antigen testing after the US Preventive Services Task Force recommendation: a population-based analysis of electronic health data
dc.typeJournal Article
dc.source.journaltitleCancer causes and control : CCC
dc.source.volume31
dc.source.issue9
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/umccts_pubs/228
dc.identifier.contextkey19895383
html.description.abstract<p>PURPOSE: This study describes longitudinal trends in the use of prostate-specific antigen (PSA)-based testing in two geographically distinct healthcare systems following the 2011 US Preventive Services Task Force (USPSTF) recommendations against routine PSA screening.</p> <p>METHODS: We analyzed population-based health claims data from 253,139 men aged 40-80 who were enrolled at two US healthcare systems. We assessed trends in the percentage of eligible men receiving >/= 1 PSA test per year by time period (2000-2008, 2009-2011, 2012-2014), age (40-54, 55-69, 70-80), and race (white, black, other, unknown), and conducted a joinpoint regression analysis.</p> <p>RESULTS: Men aged 55-69 and 70-80 years of all races had similar use of PSA testing between 2000 and 2011, ranging between 47 and 56% of eligible men by year, while only 22-26% of men aged 40-54 had a PSA test per year during this period. Overall, the percentage of men receiving at least one PSA test per year decreased by 26% between 2009-2011 and 2012-2014, with similar trends across race and age groups. PSA testing declined significantly after 2011 (annual percent change = - 11.28).</p> <p>CONCLUSIONS: Following the 2011 USPSTF recommendations against routine PSA screening, declines in PSA testing were observed among men of all races and across all age groups in two large US healthcare systems.</p>
dc.identifier.submissionpathumccts_pubs/228
dc.contributor.departmentUrology
dc.contributor.departmentMeyers Primary Care Institute
dc.contributor.departmentMedicine
dc.contributor.departmentPopulation and Quantitative Health Sciences
dc.contributor.departmentUMass Chan Analytics
dc.source.pages861-867


This item appears in the following Collection(s)

Show simple item record